Neuroscientist, 2010 · DOI: 10.1177/1073858409355830 · Published: April 1, 2010
Matrix metalloproteinases (MMPs) are a family of enzymes involved in tissue remodeling and wound healing. In the central nervous system (CNS), MMPs are implicated in neurodegenerative diseases and stroke-related damage. While increased MMP activity is often associated with damage in the CNS, research also suggests that MMPs participate in recovery processes after traumatic injuries to the adult and developing CNS. The specific roles of MMPs in the CNS depend on the timing and context of their activity, influencing both injury and repair mechanisms following neurotrauma.
Early blockade of MMPs may stabilize the blood-brain barrier, reduce edema, and provide neuroprotection following CNS trauma.
Developing specific MMP inhibitors could allow for targeted intervention to minimize detrimental effects while preserving beneficial roles in wound healing.
The timing of MMP inhibition is critical, as prolonged broad-spectrum inhibition may impair recovery processes.